JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB7006

Goat F(ab')2 Anti-Human IgG H&L (PE) preadsorbed

Be the first to review this product! Submit a review

|

(6 Publications)

Suitable for Flow Cyt, IM, IHC-Fr, IHC-P, ICC/IF, Dot. Preadsorbed to minimise non-specific binding and high background staining. Cited in 6 publications.

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1, Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4, Immunoglobulin heavy constant gamma 3, HDC, Heavy chain disease protein, Ig gamma-3 chain C region, IGHG3, Immunoglobulin heavy constant gamma 2, Ig gamma-2 chain C region, Ig gamma-2 chain C region DOT, Ig gamma-2 chain C region TIL, Ig gamma-2 chain C region ZIE, IGHG2

1 Images
Dot Blot - Goat F(ab')2 Anti-Human IgG H&L (PE) preadsorbed (AB7006)
  • Dot

Supplier Data

Dot Blot - Goat F(ab')2 Anti-Human IgG H&L (PE) preadsorbed (AB7006)

Dot blot analysis of ab7006. Imaged with BioRad ChemiDoc, Rhodamine filter.

All lanes:

Dot Blot - Goat F(ab')2 Anti-Human IgG H&L (PE) preadsorbed (ab7006)

Lane 1:

Human IgG at 100 ng

Lane 2:

Human IgG at 33.3 ng

Lane 3:

Human IgG at 11.1 ng

Lane 4:

Human IgG at 3.7 ng

Lane 5:

Human IgG at 1.23 ng

Secondary

All lanes:

Goat F(ab')2 Anti-Human IgG Antibody RPE at 1 µg/mL

false

Key facts

Host species

Goat

Target species

Human

Target isotype

IgG

Target specificity

Heavy & Light chains

Minimal cross-reactivity

Rat, Horse, Cow, Mouse

Pre-adsorbed

Yes

Conjugation

PE

Excitation/Emission

Ex: 480;565nm, Em: 578nm

Applications

Dot, IHC-P, IM, ICC/IF, Flow Cyt, IHC-Fr

applications

Clonality

Polyclonal

Isotype

IgG

Immunogen

Native Full Length Protein corresponding to Human IGHG1.

P01857

Specificity

No reaction was observed against anti-Pepsin, anti-Goat IgG F(c), or Bovine, Horse, Mouse and Rat Serum Proteins.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Flow Cyt": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"1/100 - 1/250", "notes":"<p>Use 1 x 10<sup>6</sup> cells in flow cytometry is approximately 1.0 ug of antibody conjugate.</p>" }, "IM": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"1/50 - 1/200", "notes":"<p></p>" }, "IHC-Fr": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"1/50 - 1/200", "notes":"<p></p>" }, "IHC-P": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"1/50 - 1/200", "notes":"<p></p>" }, "ICC/IF": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"1/100 - 1/250", "notes":"<p></p>" }, "Dot": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Can be used in immunomicroscopy and flow cytometry or FACS analysis as well as other antibody based fluorescent assays requiring extremely low background levels, absence of F(c) mediated binding, lot-to-lot consistency, high titer and specificity.

Properties and storage information

Form
Lyophilized
Purification technique
Affinity purification Immunogen
Purification notes
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Human IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities, pepsin digestion and chromatographic separation.
Storage buffer
pH: 7.2 Preservative: 0.05% Sodium azide Constituents: 1% BSA, 0.88% Sodium chloride, 0.424% Potassium phosphate solution
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

Target data

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses.
See full target information IGHG1

Additional targets

IGHG3,IGHG2,IGHG4

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

JCI insight 8: PubMed37606046

2023

Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination.

Applications

Unspecified application

Species

Unspecified reactive species

Hiromitsu Asashima,Dongjoo Kim,Kaicheng Wang,Nikhil Lele,Nicholas C Buitrago-Pocasangre,Rachel Lutz,Isabella Cruz,Khadir Raddassi,William E Ruff,Michael K Racke,JoDell E Wilson,Tara S Givens,Alba Grifoni,Daniela Weiskopf,Alessandro Sette,Steven H Kleinstein,Ruth R Montgomery,Albert C Shaw,Fangyong Li,Rong Fan,David A Hafler,Mary M Tomayko,Erin E Longbrake

Cells 9: PubMed32059493

2020

Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defend Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Nicoleta Alexandru,Eugen Andrei,Florentina Safciuc,Emanuel Dragan,Ana Maria Balahura,Elisabeta Badila,Adriana Georgescu

Current protocols in stem cell biology 44:2A.11.1-2A.11.13 PubMed29512129

2018

Controlling the Effective Oxygen Tension Experienced by Cells Using a Dynamic Culture Technique for Hematopoietic Ex Vivo Expansion.

Applications

Unspecified application

Species

Unspecified reactive species

Abhilasha Tiwari,Cynthia S Wong,Lakshmi P Nekkanti,James A Deane,Courtney McDonald,Jingang Li,Yen Pham,Amy E Sutherland,Graham Jenkin,Mark A Kirkland

Scientific reports 6:28643 PubMed27345490

2016

Intramolecular trimerization, a novel strategy for making multispecific antibodies with controlled orientation of the antigen binding domains.

Applications

Unspecified application

Species

Unspecified reactive species

Ana Alvarez-Cienfuegos,Natalia Nuñez-Prado,Marta Compte,Angel M Cuesta,Ana Blanco-Toribio,Seandean Lykke Harwood,Maider Villate,Nekane Merino,Jaume Bonet,Rocio Navarro,Clara Muñoz-Briones,Karen Marie Juul Sørensen,Kasper Mølgaard,Baldo Oliva,Laura Sanz,Francisco J Blanco,Luis Alvarez-Vallina

Current protocols in stem cell biology 36:1C.15.1-1C.15.16 PubMed26840223

2016

Expansion of Human Hematopoietic Stem/Progenitor Cells on Decellularized Matrix Scaffolds.

Applications

Unspecified application

Species

Unspecified reactive species

Abhilasha Tiwari,Melinda L Tursky,Lakshmi P Nekkanti,Graham Jenkin,Mark A Kirkland,Gopal Pande

Current protocols in stem cell biology 28:Unit 1C.15. PubMed24510768

2014

Expansion of human hematopoietic stem/progenitor cells on decellularized matrix scaffolds.

Applications

Unspecified application

Species

Unspecified reactive species

Abhilasha Tiwari,Melinda L Tursky,Mark A Kirkland,Gopal Pande
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com